Technical Description
The present invention provides an injectable hydrogel composition loaded with N-acetylglycine for stabilizing mutant and misfolded proteins responsible for genetic disorders by effectively binding with the mutant protein.
Problems Addressed
- Complicated Process
- High Cost & Toxicity
- Inefficient Existing Systems
- Rapid Drug Release
- Low Stability
Tech Features
- Stabilizes Mutant Proteins
- Allows Correct Protein Folding
- Slow & Sustained Release
- Long-Lasting Therapeutic Effect
- Less Pain
- Cost-Effective
- Non-Toxic
Target Audience
- Healthcare & Medical Sector
- Biotechnology Industry
- Pharmaceutical Industry
- Research & Development
Tech ID: P21-1543 TRL 4 Patent Status: Published Available For Exclusive and Non-exclusive License
